Edgemoor Investment Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-206,748
Closed -$8.82M 136
2015
Q4
$8.82M Sell
206,748
-4,060
-2% -$187K 1.32% 25
2015
Q3
$10M Buy
210,808
+14,750
+8% +$751K 1.52% 20
2015
Q2
$9.71M Buy
196,058
+9,540
+5% +$483K 1.42% 22
2015
Q1
$9.22M Buy
186,518
+37,075
+25% +$1.77M 1.31% 28
2014
Q4
$6.82M Buy
149,443
+31,283
+26% +$1.52M 1% 39
2014
Q3
$6.64M Buy
118,160
+30,410
+35% +$1.63M 0.98% 45
2014
Q2
$4.67M Buy
87,750
+53,560
+157% +$2.84M 0.69% 52
2014
Q1
$1.79M Buy
34,190
+11,795
+53% +$597K 0.28% 72
2013
Q4
$1.2M Buy
+22,395
New +$1.16M 0.19% 80

Other funds holding SNY

Edgemoor Investment Advisors's SNY Position: Q1 2016 in Review

Edgemoor Investment Advisors sold out of Sanofi (SNY) in Q1 2016, closing a stake of 206,748 shares — an estimated $8.82M sold.

Edgemoor Investment Advisors first reported a position in SNY in Q4 2013 and held it in 9 quarters. The position peaked at $10M in Q3 2015. 448 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

  • Edgemoor Investment Advisors reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
  • Edgemoor Investment Advisors sold 206,748 Sanofi shares in Q1 2016, an estimated $8.82M.
  • Edgemoor Investment Advisors first reported a position in Sanofi in Q4 2013 and held it in 9 quarters.
  • Edgemoor Investment Advisors's Sanofi position peaked at $10M in Q3 2015.
  • 448 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.